1981
DOI: 10.1016/0196-9781(81)90038-3
|View full text |Cite
|
Sign up to set email alerts
|

Actions of GIP

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
25
0

Year Published

1984
1984
2013
2013

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 47 publications
(26 citation statements)
references
References 17 publications
1
25
0
Order By: Relevance
“…Another incretin, glucose-dependent insulinotropic polypeptide (GIP) is a 42-amino acid hormone that is produced by enteroendocrine K-cells (4). Like GLP-1, GIP stimulates insulin secretion in a glucose-dependent manner (5). GIP regulates lipid metabolism through direct actions on adipose tissues and is involved in bone formation through stimulation of osteoblast proliferation and inhibition of apoptosis (6).…”
mentioning
confidence: 99%
“…Another incretin, glucose-dependent insulinotropic polypeptide (GIP) is a 42-amino acid hormone that is produced by enteroendocrine K-cells (4). Like GLP-1, GIP stimulates insulin secretion in a glucose-dependent manner (5). GIP regulates lipid metabolism through direct actions on adipose tissues and is involved in bone formation through stimulation of osteoblast proliferation and inhibition of apoptosis (6).…”
mentioning
confidence: 99%
“…GIP is a 42 amino acid polypeptide hormone which has been known as both gastric acid inhibitory polypeptide [l] and glucose-dependent insulinotropic polypeptide [2,3]. The polypeptide was initially isolated from porcine upper small intestine [4] where it has been localised to a discrete endocrine cell type called the K cell [S].…”
Section: Introductionmentioning
confidence: 99%
“…A peptide corresponding to GIP was identified and it was suggested that enzymatic cleavage resulted in formation of the N-terminally truncated molecule 11 . GIP was shown to be non-insulinotropic in the perfused rat pancreas 10 and isolated islets. Mentlein et al 12 first reported that GIP 1-42 was a substrate for DPIV, with release of Tyr 1 -Ala 2 .…”
Section: Problems With Gip Analogue Developmentmentioning
confidence: 99%
“…therapeutic use are that it is rapidly degraded in the bloodstream and that type 2 diabetic patients exhibit resistance to GIP action. The first indication that GIP was a target for DPIV degradation was obtained in HPLC studies on partially purified fractions from porcine intestinal extracts 10 . A peptide corresponding to GIP 3-42 was identified and it was suggested that enzymatic cleavage resulted in formation of the N-terminally truncated molecule 11 .…”
Section: Problems With Gip Analogue Developmentmentioning
confidence: 99%
See 1 more Smart Citation